Coumazoline
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392204This classification denotes an alpha-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TR7Y641235. European Medicines Agency schedules Coumazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06815MIG. Coumazoline generally arises in the molecular formula C14H16N2O. The term COUMAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, no. 10 1972, list 12.) COUMAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule coumazoline under HS 29349990 and SITC 51579. As of Q4 2014, COUMAZOLINE remains the US FDA Preferred Term for this commodity. Coumazoline bears US NLM identifiers UMLS ID C0602991 and NCI Concept Code C79706. SMILES: O1C(C(CC2=NCCN2)C2C1CCCC2)CC.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.